The rate of distant recurrences was similar for systemically untreated patients with high-expressing PTPN2 tumours as well as low-expressing (high vs low, HR = 1.22, 95% CI 0.80–1.86, P = 0.37). This evidence concerns the gene PTPN2 and neoplasm.